Perhaps these different microglial transcriptional programs feature in different aspects of AD pathology, as shown in a human study where it was thought that one microglial transcriptional program contributed to tau pathology and two others to β-amyloid pathology [252]. This evidence concerns the gene MAPT and Alzheimer disease.